Target
Alpha-2C adrenergic receptor
Ligand
BDBM50253157
Substrate
n/a
Meas. Tech.
ChEMBL_1804485 (CHEMBL4303088)
Ki
224±n/a nM
Citation
 Gordon, DEJang, GMBouhaddou, MXu, JObernier, KWhite, KMO'Meara, MJRezelj, VVGuo, JZSwaney, DLTummino, TAHüttenhain, RKaake, RMRichards, ALTutuncuoglu, BFoussard, HBatra, JHaas, KModak, MKim, MHaas, PPolacco, BJBraberg, HFabius, JMEckhardt, MSoucheray, MBennett, MJCakir, MMcGregor, MJLi, QMeyer, BRoesch, FVallet, TMac Kain, AMiorin, LMoreno, ENaing, ZZCZhou, YPeng, SShi, YZhang, ZShen, WKirby, ITMelnyk, JEChorba, JSLou, KDai, SABarrio-Hernandez, IMemon, DHernandez-Armenta, CLyu, JMathy, CJPPerica, TPilla, KBGanesan, SJSaltzberg, DJRakesh, RLiu, XRosenthal, SBCalviello, LVenkataramanan, SLiboy-Lugo, JLin, YHuang, XPLiu, YWankowicz, SABohn, MSafari, MUgur, FSKoh, CSavar, NSTran, QDShengjuler, DFletcher, SJO'Neal, MCCai, YChang, JCJBroadhurst, DJKlippsten, SSharp, PPWenzell, NAKuzuoglu-Ozturk, DWang, HYTrenker, RYoung, JMCavero, DAHiatt, JRoth, TLRathore, USubramanian, ANoack, JHubert, MStroud, RMFrankel, ADRosenberg, OSVerba, KAAgard, DAOtt, MEmerman, MJura, Nvon Zastrow, MVerdin, EAshworth, ASchwartz, Od'Enfert, CMukherjee, SJacobson, MMalik, HSFujimori, DGIdeker, TCraik, CSFloor, SNFraser, JSGross, JDSali, ARoth, BLRuggero, DTaunton, JKortemme, TBeltrao, PVignuzzi, MGarcía-Sastre, AShokat, KMShoichet, BKKrogan, NJ A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459-468 (2020) [PubMed]  Article 
Target
Name:
Alpha-2C adrenergic receptor
Synonyms:
ADA2C_HUMAN | ADRA2C | ADRA2L2 | ADRA2RL2 | Adrenergic alpha2C | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2C-, receptor | Alpha-2 adrenergic receptor subtype C4 | Alpha-2C adrenoceptor | Alpha-2C adrenoreceptor | adrenergic, alpha-2C-, receptor [Homo sapiens]
Type:
Enzyme
Mol. Mass.:
49552.32
Organism:
Homo sapiens (Human)
Description:
P18825
Residue:
462
Sequence:
MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ
  
Inhibitor
Name:
BDBM50253157
Synonyms:
(+)-(2R)-2-(2-(((R)-p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine | (+)-(2R)-2-[2-[[(R)-p-chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine | (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine | CHEMBL1626 | CLEMASTINE
Type:
Small organic molecule
Emp. Form.:
C21H26ClNO
Mol. Mass.:
343.89
SMILES:
CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: